Zuoli Pharmaceutical: Record of Investor Relations Activities from March 17, 2025 to March 19, 2025
Zuoli Pharmaceutical: Record of Investor Relations Activities from March 9, 2025 to March 11, 2025
Zoli Pharmaceuticals: 2024 Annual Results Report
Zuoli Pharmaceutical: Announcement on receipt of the 2024 profit distribution proposal letter from the controlling shareholder, actual controller and chairman
Zuli Pharmaceuticals: Earnings Forecast for the First Quarter of 2025
Zuoli Pharmaceutical: Announcement on changes in the company\'s pharmaceutical production license
Zuoli Pharmaceutical: Investor Relations Activity Record Form from February 18, 2025 to February 21, 2025
Zuoli Pharmaceuticals: Investor Relations Activity Record Form for February 12, 2025
Zuoli Pharmaceutical: Announcement on the company\'s participation in the centralized procurement of proprietary Chinese medicines such as Jinlianhua capsules from Guangdong Union to be selected
Zuli Pharmaceutical: Announcement on the completion of the non-transactional transfer of shares transferred for the first time in the 2024 Employee Stock Ownership Plan
Zuli Pharmaceutical: Announcement of Resolutions of the 2024 Employee Stock Owners\' Meeting on the 2024 Employee Stock Ownership Plan
Zuoli Pharmaceuticals: Investor Relations Activity Record Form for January 10, 2025
Zuli Pharmaceutical: Supervisory Board\'s Review Opinions on the List of Incentives Granted for the First Time in the 2024 Restricted Stock Incentive Plan (as of the grant date)
Zuoli Pharmaceutical: Announcement on Adjusting the Shareholders\' Shares of the Company\'s 2024 Employee Stock Ownership Plan
Zuoli Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Directors
Zuoli Pharmaceutical: Announcement on granting restricted shares for the first time to incentive recipients of the 2024 Restricted Stock Incentive Program
Zuli Pharmaceutical: List of recipients of incentives granted for the first time in the 2024 Restricted Stock Incentive Plan (as of the grant date)
Zuoli Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2024 Restricted Stock Incentive Plan Adjustment and First Grant of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuoli Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Supervisors
Zuoli Pharmaceutical: Announcement on matters relating to the adjustment of the company\'s 2024 restricted stock incentive plan